Capranico G - Search Results

1

Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance.

Capranico G, Supino R, Binaschi M, Capolongo L, Grandi M, Suarato A, Zunino F. Capranico G, et al. Mol Pharmacol. 1994 May;45(5):908-15. Mol Pharmacol. 1994. PMID: 8190107

2

Current approaches to new drug development in cancer chemotherapy.

Zunino F, Capranico G, Pratesi G, Spinelli S. Zunino F, et al. Among authors: capranico g. Farmaco. 1992 Sep;47(9):1115-32. Farmaco. 1992. PMID: 1300118 Review.

3

Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.

Giaccone G, Gazdar AF, Beck H, Zunino F, Capranico G. Giaccone G, et al. Among authors: capranico g. Cancer Res. 1992 Apr 1;52(7):1666-74. Cancer Res. 1992. PMID: 1312895

4

DNA topoisomerase-trapping antitumour drugs.

Capranico G, Zunino F. Capranico G, et al. Eur J Cancer. 1992;28A(12):2055-60. doi: 10.1016/0959-8049(92)90255-z. Eur J Cancer. 1992. PMID: 1329885 Review. No abstract available.

5

Characterization of a topoisomerase II gene rearrangement in a human small-cell lung cancer cell line.

Binaschi M, Giaccone G, Gazdar AF, De Isabella P, Ricotti GC, Capranico G, Zunino F. Binaschi M, et al. Among authors: capranico g. J Natl Cancer Inst. 1992 Nov 18;84(22):1710-6. doi: 10.1093/jnci/84.22.1710. J Natl Cancer Inst. 1992. PMID: 1331483

6

Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development.

Capranico G, Tinelli S, Austin CA, Fisher ML, Zunino F. Capranico G, et al. Biochim Biophys Acta. 1992 Aug 17;1132(1):43-8. doi: 10.1016/0167-4781(92)90050-a. Biochim Biophys Acta. 1992. PMID: 1380833

7

The role of topoisomerase II in drug resistance.

De Isabella P, Capranico G, Zunino F. De Isabella P, et al. Among authors: capranico g. Life Sci. 1991;48(23):2195-205. doi: 10.1016/0024-3205(91)90333-7. Life Sci. 1991. PMID: 1646358 Review.

8

DNA topoisomerase II as the primary target of anti-tumor anthracyclines.

Zunino F, Capranico G. Zunino F, et al. Among authors: capranico g. Anticancer Drug Des. 1990 Nov;5(4):307-17. Anticancer Drug Des. 1990. PMID: 1963303 Review.

9

Relationships among tumor responsiveness, cell sensitivity, doxorubicin cellular pharmacokinetics and drug-induced DNA alterations in two human small-cell lung cancer xenografts.

Pratesi G, Capranico G, Binaschi M, De Isabella P, Pilotti S, Supino R, Zunino F. Pratesi G, et al. Among authors: capranico g. Int J Cancer. 1990 Oct 15;46(4):669-74. doi: 10.1002/ijc.2910460420. Int J Cancer. 1990. PMID: 1976600

10

Evidence of DNA topoisomerase II-dependent mechanisms of multidrug resistance in P388 leukemia cells.

De Isabella P, Capranico G, Binaschi M, Tinelli S, Zunino F. De Isabella P, et al. Among authors: capranico g. Mol Pharmacol. 1990 Jan;37(1):11-6. Mol Pharmacol. 1990. PMID: 2153905

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters